AzTrials
AzTrials

Labor, Induced"PRIME"NCT01641601

Prehospital Cervical Ripening Before Induction and the Maternal Experience

A study testing Outpatient transcervical Foley balloon in people with Labor, Induced and Cervical Ripening, run by University of California, San Francisco at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This is a randomized study evaluating the impact of pre-hospital cervical ripening with a transcervical Foley balloon before labor induction in full-term pregnancies on the length of inpatient labor induction and maternal satisfaction with the labor induction process. Read more about this study

Who is it for?
Ages 15 to 50 years, women only
Conditions the study is for
Labor, Induced, Cervical Ripening
What is being tested?
Outpatient transcervical Foley balloon
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteUnited States
Study dates
Jul 2012to Jul 2015
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 50 years
  • Women only
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Intrauterine pregnancy
  • Cephalic presentation
  • Greater than 36 weeks estimated gestational age
  • Reassuring fetal status
  • Normal amniotic fluid index
  • Clinical indication for induction of labor

Who cannot join

  • Prior cesarean section
  • Bishop score on cervical examination ≥ 6
  • Unreliable transportation
  • Home > 30 minutes from the hospital
  • Non-reassuring fetal status
  • Abnormal amniotic fluid index
  • Other indication for immediate hospitalization

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UCSF Benioff Children's Hospital

    San Francisco, California, 94143

Other trials in United States

About this study

Official title: Randomized Controlled Trial of Prehospital Cervical Ripening With an Outpatient Transcervical Foley Balloon and the Duration of Induction and Maternal Satisfaction

This is a randomized study evaluating the impact of pre-hospital cervical ripening with a transcervical Foley balloon before labor induction in full-term pregnancies on the length of inpatient labor induction and maternal satisfaction with the labor induction process. The investigators hypothesize that women who receive pre-hospital cervical ripening will have a shorter duration of inpatient labor induction as compared to women without pre-hospital cervical ripening.

Read the detailed description

Labor induction is a common procedure among pregnant patients at term. This process involves a period of cervical preparation ("ripening") for women who have an "unfavorable" cervical examination at the time labor induction is scheduled. Cervical ripening may take place with pharmacologic or mechanical strategies, which at this time are traditionally administered on an inpatient basis. This process can 24 or more hours, resulting in a lengthy hospitalization with the associated costs and frustrations for both patients and L\&D staff.

The proposed study is a randomized, controlled trial to explore the following research question: Among women with full-term pregnancies requiring labor induction, does pre-hospital, outpatient cervical ripening reduce the amount of inpatient time needed to achieve delivery as compared to no pre-hospital cervical ripening? As a secondary objective, we also wish to explore if outpatient cervical ripening is acceptable to patients.

This study will involve randomizing eligible and consenting women who have been scheduled for labor induction by their obstetrical providers into a pre-hospital cervical ripening (intervention) group or a no pre-hospital ripening (control) group. A trans-cervical Foley balloon (TCFB) will be used for outpatient pre-hospital cervical ripening in women randomized to the intervention group. No pre-hospital ripening will be performed for women in the control group. Both groups will be admitted for induction as scheduled and will undergo labor induction according to a specified, Bishop-score based induction protocol, which may or may not include a TCFB. We will compare the duration of inpatient stays from admission until delivery between the groups as well as satisfaction with the pre-hospital period and labor and delivery experience. Maternal and neonatal outcomes will also be compared between the two groups.

Being tested
Outpatient transcervical Foley balloon
Keywords
Induction of labor, Outpatient cervical ripening

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Outpatient transcervical Foley balloonDevice

    A 30 cc transcervical Foley balloon will be placed in the outpatient setting prior to labor induction.

Study groups in NCT01641601
Study groupRoleWhat they receive
Usual ManagementNo interventionPatients in the usual management arm will have no pre-hospital cervical ripening and will undergo labor induction according to standard labor induction protocols on an inpatient basis.
Outpatient transcervical Foley balloonExperimentalPatients in the experimental group will have a 30 cc transcervical Foley balloon placed in the outpatient setting approximately 12-18 hours prior to their labor induction. Once admitted, they will undergo inpatient labor induction as per usual protocols.
Receives: Device: Outpatient transcervical Foley balloon

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Duration of Inpatient Time Required to Achieve Delivery

    Time from admission to the hospital until delivery

    Measured: From admission to delivery, expected average of 48 hours

Secondary outcomes (1)
  1. Maternal Satisfaction

    Maternal satisfaction with the period leading up to admission and the hospital stay, measured by interview.

    Measured: up to 48 hours after delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2012 (estimated)
  2. Study startJul 2012
  3. Primary completionJul 2015
  4. Study completionJul 2015

Why it stopped: Inadequate enrollment. Key study personnel transitioned to a different role.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
8 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01641601
Sponsor's protocol ID
12-08620
Acronym
"PRIME"
Status last verified
Jul 2020
First submitted
3 Jul 2012
Last updated
5 Aug 2020
Data monitoring committee
No

Publications

  • de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4.

    PubMed 36996264

Questions about this trial

What is this clinical trial studying?

A study testing Outpatient transcervical Foley balloon in people with Labor, Induced and Cervical Ripening, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 5 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 5 Aug 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Duration of Inpatient Time Required to Achieve Delivery (time frame: From admission to delivery, expected average of 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01641601, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in